NutriBand (NTRB) EBT Margin (2018 - 2026)

NutriBand's (NTRB) quarterly EBT Margin came in at 241.59% in Q1 2026, up 61716.0% year-on-year from N/an in Q1 2025, and up 78.41% quarter-over-quarter from 1118.99% in Q4 2025.

NutriBand (NTRB) EBT Margin (2018 - 2026) Analysis & Trends

NutriBand has disclosed EBT Margin across 9 years of filings, most recently posting 241.59% for Q1 2026.

  • EBT Margin for Q1 2026 came in at 241.59%, up 61716.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 404.08% (up 8587.0% YoY), and the FY2026 annual result was 404.08%, up 8587.0% from the prior year.
  • EBT Margin came in at 241.59% for Q1 2026 at NutriBand, up from 1118.99% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 126.41% in Q3 2023 to a low of 1118.99% in Q4 2025.
  • The 5-year median for EBT Margin is 318.33% (2023), against an average of 385.25%.
  • Across the five-year window, EBT Margin plunged 90799 bps in 2025 and soared 61716 bps in 2026, its largest moves.
  • NutriBand's EBT Margin stood at 174.03% in 2022, then slumped by 136 bps to 411.36% in 2023, then soared by 49 bps to 211.0% in 2024, then slumped by 430 bps to 1118.99% in 2025, then surged by 78 bps to 241.59% in 2026.
  • The last three EBT Margin figures came in at 241.59% (Q1 2026), 1118.99% (Q4 2025), and 321.36% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 6.40%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 41.95%
9 Abivax 94.37 Bn 94.37 Bn - -
10 NutriBand 41.91 Mn 37.33 Mn 88,941.00 -241.59%

Historic Data

Download Data
DateValue
Jan 31, 2026 -241.59%
Oct 31, 2025 -1,118.99%
Jul 31, 2025 -321.36%
Apr 30, 2025 -208.09%
Jan 31, 2025 -858.75%
Oct 31, 2024 -211.00%
Jul 31, 2024 -385.13%
Apr 30, 2024 -464.61%
Jan 31, 2024 -358.54%
Oct 31, 2023 -411.36%
Jul 31, 2023 -126.41%
Apr 30, 2023 -212.87%
Jan 31, 2023 -318.33%
Oct 31, 2022 -174.03%
Jul 31, 2022 -227.71%
Apr 30, 2022 -144.37%
Jan 31, 2022 -766.11%
Oct 31, 2021 -555.34%
Jul 31, 2021 -243.25%
Apr 30, 2021 -72.68%